Massachusetts General Hospital Dana-Farber Cancer Institute — Boston, Massachusetts

Massachusetts General Hospital Dana-Farber Cancer Institute is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital Dana-Farber Cancer Institute has participated in 8 clinical trials with 2 currently active.

Therapeutic areas: Advanced Solid Tumor, Neoplasms, Estrogen Receptor-positive Breast Cancer.

Sponsors: Novartis Pharmaceuticals, Celgene, Vanderbilt-Ingram Cancer Center.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

• Massachusetts General Hospital Translational and Clinical Research Center
• Boston VA CSP Coordinating Center
• Boston Children's Hospital / Dana Farber Cancer Institute / Massachusetts General Hospital
• Massachusetts General Hospital Site Number : 002
• Laboratories of Cognitive Neuroscience, Boston Children's Hospital
• The Brigham and Women's Hospital Department of Anesthesiology
• Tuft University Hospital
• Boston Children's Hospital /ID# 162863
• Dana Farber Cancer Institute/Children's Hospital of Boston
• Brigham and Women's Hospital
• Brigham & Woman's Hospital/Boston
• Caritus St. Elizabeth's Hospital

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital Dana-Farber Cancer Institute?

Massachusetts General Hospital Dana-Farber Cancer Institute has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital Dana-Farber Cancer Institute conducted?

Massachusetts General Hospital Dana-Farber Cancer Institute has 8 clinical trials on record, with 2 currently active. Their work covers Advanced Solid Tumor, Neoplasms, Estrogen Receptor-positive Breast Cancer.

Is Massachusetts General Hospital Dana-Farber Cancer Institute accredited by Crixeo Clinical Trials?

Massachusetts General Hospital Dana-Farber Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital Dana-Farber Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.